JNJ · GPK 10-KMar 2 '26
“Health/beauty customers include GlaxoSmithKline, Bayer, Johnson & Johnson, Abbott, Novartis, L'Oréal S.A., Procter & Gamble and Colgate-Palmolive.”
ABT · GPK 10-KMar 2 '26
“Health/beauty customers include GlaxoSmithKline, Bayer, Johnson & Johnson, Abbott, Novartis, L'Oréal S.A., Procter & Gamble and Colgate-Palmolive.”
| Stage | JNJ | % of rev | ABT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $25.4B | 100.00% | $12.6B | 100.00% | JNJ ×2.02 |
| Gross profit | $17.3B | 68.12% | $7.3B | 57.71% | JNJ +10.4pp |
| Operating income | $5.8B | 23.01% | $1.7B | 13.44% | JNJ +9.6pp |
| Pre-tax income | $34M | 0.13% | $1.5B | 12.10% | ABT +12.0pp |
| Net income | $210M | 0.83% | $928M | 7.37% | ABT +6.5pp |
| Stage | JNJ | ABT | Gap · A − B |
|---|---|---|---|
| Revenue | $25.4B100.00% | $12.6B100.00% | JNJ ×2.02 |
| Gross profit | 68.12%$17.3B | 57.71%$7.3B | JNJ +10.4pp |
| Operating income | 23.01%$5.8B | 13.44%$1.7B | JNJ +9.6pp |
| Pre-tax income | 0.13%$34M | 12.10%$1.5B | ABT +12.0pp |
| Net income | 0.83%$210M | 7.37%$928M | ABT +6.5pp |